Harpoon Therapeutics, Inc. Gains 111.94%
Mon, Jan 08, 2024 at 07:36 PM
Harpoon Therapeutics, Inc. (HARP:NASDAQ) shot up at $22.36, representing a gain of 111.9%. On Mon, Jan 08, 2024, HARP:NASDAQ touched a New 2-Week High of $22.36. The stock appeared on our News Catalysts scanner on Mon, Jan 08, 2024 at 04:49 PM in the 'BIOTECH' category. From Tue, Dec 26, 2023, the stock recorded 25.00% Up Days and 33.33% Green Days
About Harpoon Therapeutics, Inc. (HARP:NASDAQ)
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 59900%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 141.94%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 111.94%
- Elevation Oncology Inc. (ELEV:NASDAQ), 106.95%
- Ambrx Biopharma Inc. (AMAM:NASDAQ), 101.54%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 101.54%
- Nkarta Inc. (NKTX:NASDAQ), 77.06%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 63.64%
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 46.15%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 45.83%